US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Q32 Bio Inc.

13.59

-0.7700-5.36%

Post-market: 13.590.00000.00%19:30 EDT

Volume:434.82K

Turnover:5.93M

Market Cap:403.74M

PE:4.53

High:14.55

Open:14.42

Low:13.35

Close:14.36

52wk High:23.57

52wk Low:1.62

Shares:29.71M

Float Shares:20.90M

Volume Ratio:1.39

T/O Rate:2.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):3.00

EPS(LYR):2.42

ROE:72.14%

ROA:14.74%

PB:3.81

PE(LYR):5.61

Loading ...

Overview Company News Filings

Q32 Bio initiated with an Overweight at Cantor Fitzgerald

Q32 Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Q32 Bio Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Henry Schein (HSIC), Viridian Therapeutics (VRDN) and Q32 Bio (QTTB)

Q32 Bio Q1 EPS $(0.54) Beats $(0.68) Estimate

Benzinga Earnings

Q32 Bio Q1 net loss narrows to $7.6 million; loss per share improves to $0.54

Press Release: Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

Q32 Bio Inc expected to post a loss of 68 cents a share - Earnings Preview

Q32 Bio announces annual shareholder meeting webcast

Q32 Bio files prospectus for USD 75 million at-the-market stock offering

Q32 Bio to join Needham Virtual Healthcare Conference fireside chat

Q32 Bio enters $14 million at-the-market equity distribution agreement; Cantor Fitzgerald commission set at 3.0%

Analysts Have Conflicting Sentiments on These Healthcare Companies: Atricure (ATRC), Q32 Bio (QTTB) and Shoulder Innovations, Inc. (SI)

Q32 Bio Faces Governance Backlash and Rising Costs After 2025 Stock Option Repricing

Q32 Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Q32 Bio Q4 net income hits USD 57.73 million as R&D expenses fall 69% to USD 3.32 million

Press Release: Q32 Bio Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update

Q32 Bio Inc expected to post a loss of 86 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/QTTB/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"QTTB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QTTB\",,,,,undefined,":{"symbol":"QTTB","market":"US","secType":"STK","nameCN":"Q32 Bio Inc.","latestPrice":13.59,"timestamp":1788379200000,"preClose":14.36,"halted":0,"volume":434819,"hourTrading":{"tag":"盘后","latestPrice":13.59,"preClose":13.59,"latestTime":"19:30 EDT","volume":16882,"amount":229454.77,"timestamp":1788391804430,"change":0,"changeRate":0,"amplitude":0.000736},"delay":0,"changeRate":-0.053621169916434515,"floatShares":20898500,"shares":29708800,"eps":3.0012,"marketStatus":"Not Yet Opened","change":-0.77,"latestTime":"09-02 16:00:00 EDT","open":14.42,"high":14.55,"low":13.35,"amount":5932416.501704,"amplitude":0.083565,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.0012,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788422400000},"marketStatusCode":0,"adr":0,"listingDate":1522209600000,"exchange":"NASDAQ","adjPreClose":14.36,"preHourTrading":{"tag":"盘前","latestPrice":14.26,"preClose":14.36,"latestTime":"09:27 EDT","volume":415,"amount":5875.60984,"timestamp":1788355660061,"change":-0.1,"changeRate":-0.006964,"amplitude":0.022284},"postHourTrading":{"tag":"盘后","latestPrice":13.59,"preClose":13.59,"latestTime":"19:30 EDT","volume":16882,"amount":229454.77,"timestamp":1788391804430,"change":0,"changeRate":0,"amplitude":0.000736},"volumeRatio":1.388409,"impliedVol":0.9996,"impliedVolPercentile":0.28},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QTTB\",,,,,undefined,":{"symbol":"QTTB","floatShares":20898500,"roa":"14.74%","roe":"72.14%","lyrEps":2.421558,"volumeRatio":1.388409,"shares":29708800,"dividePrice":0,"high":14.55,"amplitude":0.083565,"preClose":14.36,"low":13.35,"week52Low":1.62,"pbRate":"3.81","psRate":"7.51","week52High":23.5699,"institutionHeld":0,"latestPrice":13.59,"eps":3.0012,"divideRate":0,"volume":434819,"delay":0,"ttmEps":3.0012,"open":14.42,"prevYearClose":3.32,"prevWeekClose":15.03,"prevMonthClose":14.87,"prevQuarterClose":12.74,"fiveDayClose":16.18,"twentyDayClose":16.49,"sixtyDayClose":12.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QTTB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"QTTB","fiscalQuarterEnding":"2026/06","expectedEps":-0.53,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":-0.44},{"market":"US","date":"2026-05-05","symbol":"QTTB","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"pre","actualEps":-0.54},{"market":"US","date":"2026-03-10","symbol":"QTTB","fiscalQuarterEnding":"2025/12","expectedEps":-0.85,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"pre","actualEps":3.65},{"market":"US","date":"2025-11-13","symbol":"QTTB","fiscalQuarterEnding":"2025/09","expectedEps":-1.39,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-0.6},{"market":"US","date":"2025-08-06","symbol":"QTTB","fiscalQuarterEnding":"2025/06","expectedEps":-1.14,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":-0.78}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QTTB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QTTB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1787716800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QTTB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QTTB","date":"2026-09-01","current":4.513195,"percent":0.960884,"low":-10.694771,"twenty":-5.409471,"median":-0.58768,"eighty":2.472502,"high":14.526974,"avg":-0.989554,"sd":5.193476,"marketCap":442671959},"quantilePoints":[{"date":"2024-04-05","current":-4.597074,"twenty":-4.75645,"median":-4.597074,"eighty":-3.952906,"marketCap":247060524},{"date":"2024-04-12","current":-5.285192,"twenty":-4.79019,"median":-4.726928,"eighty":-4.38975,"marketCap":284042061},{"date":"2024-04-19","current":-5.411717,"twenty":-5.438798,"median":-4.767993,"eighty":-4.57532,"marketCap":290841892},{"date":"2024-04-26","current":-6.268535,"twenty":-5.702502,"median":-5.138689,"eighty":-4.700069,"marketCap":336889870},{"date":"2024-05-03","current":-5.72026,"twenty":-5.938238,"median":-5.411717,"eighty":-4.727594,"marketCap":307423936},{"date":"2024-05-10","current":-5.948893,"twenty":-5.966207,"median":-5.603724,"eighty":-4.749348,"marketCap":319711350},{"date":"2024-05-17","current":-6.881182,"twenty":-6.171755,"median":-5.72026,"eighty":-4.765329,"marketCap":369815368},{"date":"2024-05-24","current":-6.526024,"twenty":-6.419477,"median":-5.852334,"eighty":-4.856783,"marketCap":350728123},{"date":"2024-05-31","current":-7.119566,"twenty":-6.557988,"median":-5.896729,"eighty":-4.946904,"marketCap":326617228},{"date":"2024-06-07","current":-5.417118,"twenty":-6.655355,"median":-5.948893,"eighty":-5.16799,"marketCap":248515704},{"date":"2024-06-14","current":-5.122964,"twenty":-6.625166,"median":-5.89118,"eighty":-5.079231,"marketCap":235021098},{"date":"2024-06-21","current":-4.172821,"twenty":-6.589953,"median":-5.833467,"eighty":-4.901621,"marketCap":191432327},{"date":"2024-06-28","current":-3.969777,"twenty":-6.557988,"median":-5.738018,"eighty":-4.86516,"marketCap":182117467},{"date":"2024-07-05","current":-4.511228,"twenty":-6.526024,"median":-5.680305,"eighty":-4.760002,"marketCap":206957095},{"date":"2024-07-12","current":-5.841429,"twenty":-6.49406,"median":-5.603724,"eighty":-4.798567,"marketCap":267981374},{"date":"2024-07-15","current":-6.825412,"twenty":-6.526024,"median":-5.660327,"eighty":-4.813855,"marketCap":313122622},{"date":"2024-08-02","current":-9.884093,"twenty":-6.542006,"median":-5.670316,"eighty":-4.829142,"marketCap":453442638},{"date":"2024-08-09","current":-7.500596,"twenty":-6.710706,"median":-5.738018,"eighty":-4.87207,"marketCap":427886482},{"date":"2024-08-16","current":-7.75207,"twenty":-6.825412,"median":-5.856316,"eighty":-4.928392,"marketCap":442232352},{"date":"2024-08-23","current":-8.155846,"twenty":-7.24299,"median":-5.902278,"eighty":-4.94491,"marketCap":465266543},{"date":"2024-08-30","current":-8.295371,"twenty":-7.548702,"median":-6.028804,"eighty":-4.98294,"marketCap":473226002},{"date":"2024-09-06","current":-9.684274,"twenty":-7.772364,"median":-6.120922,"eighty":-4.998807,"marketCap":552458796},{"date":"2024-09-13","current":-9.610284,"twenty":-8.191784,"median":-6.244914,"eighty":-5.018839,"marketCap":548237871},{"date":"2024-09-20","current":-9.971779,"twenty":-8.294103,"median":-6.360654,"eighty":-5.041746,"marketCap":568860105},{"date":"2024-09-27","current":-9.599714,"twenty":-8.935493,"median":-6.526024,"eighty":-5.050076,"marketCap":547634882},{"date":"2024-10-04","current":-9.037388,"twenty":-9.107996,"median":-6.621961,"eighty":-5.093809,"marketCap":515555851},{"date":"2024-10-11","current":-9.978122,"twenty":-9.382394,"median":-6.703603,"eighty":-5.220301,"marketCap":569221899},{"date":"2024-10-18","current":-10.49394,"twenty":-9.484712,"median":-6.794175,"eighty":-5.315929,"marketCap":598647777},{"date":"2024-10-25","current":-10.06691,"twenty":-9.672968,"median":-6.825412,"eighty":-5.346971,"marketCap":574287009},{"date":"2024-10-31","current":-9.792089,"twenty":-9.748541,"median":-7.119566,"eighty":-5.360507,"marketCap":558609287},{"date":"2024-11-08","current":-9.443128,"twenty":-9.802236,"median":-7.283651,"eighty":-5.372344,"marketCap":572357443},{"date":"2024-11-15","current":-7.16039,"twenty":-9.789552,"median":-7.500596,"eighty":-5.379633,"marketCap":433998376},{"date":"2024-11-22","current":-5.434099,"twenty":-9.773909,"median":-7.256318,"eighty":-5.396215,"marketCap":329366155},{"date":"2024-11-29","current":-5.407973,"twenty":-9.752346,"median":-7.139978,"eighty":-5.371303,"marketCap":327782663},{"date":"2024-12-06","current":-4.760865,"twenty":-9.734588,"median":-6.825412,"eighty":-5.339276,"marketCap":288560806},{"date":"2024-12-13","current":-0.854102,"twenty":-9.716407,"median":-6.794175,"eighty":-5.114636,"marketCap":51767979},{"date":"2024-12-20","current":-0.671224,"twenty":-9.680505,"median":-6.703603,"eighty":-5.031844,"marketCap":40683541},{"date":"2024-12-27","current":-0.719455,"twenty":-9.66543,"median":-6.637987,"eighty":-4.975898,"marketCap":43606909},{"date":"2025-01-03","current":-0.69333,"twenty":-9.621313,"median":-6.605935,"eighty":-4.929676,"marketCap":42023418},{"date":"2025-01-10","current":-0.657156,"twenty":-9.603942,"median":-6.526024,"eighty":-4.86516,"marketCap":39830892},{"date":"2025-01-17","current":-0.631031,"twenty":-9.545173,"median":-6.362567,"eighty":-4.746844,"marketCap":38247401},{"date":"2025-01-24","current":-0.677253,"twenty":-9.492745,"median":-6.288512,"eighty":-4.6939,"marketCap":41048962},{"date":"2025-01-31","current":-0.655147,"twenty":-9.465263,"median":-6.219701,"eighty":-4.511228,"marketCap":39709085},{"date":"2025-02-07","current":-0.63505,"twenty":-9.453365,"median":-6.05877,"eighty":-3.980076,"marketCap":38491015},{"date":"2025-02-14","current":-0.538587,"twenty":-9.43896,"median":-5.948893,"eighty":-0.813105,"marketCap":32644278},{"date":"2025-02-21","current":-0.488345,"twenty":-9.423405,"median":-5.89118,"eighty":-0.724279,"marketCap":29599103},{"date":"2025-02-28","current":-0.450162,"twenty":-9.384931,"median":-5.843753,"eighty":-0.704182,"marketCap":27284770},{"date":"2025-03-07","current":-0.468249,"twenty":-9.351106,"median":-5.738018,"eighty":-0.689713,"marketCap":28381033},{"date":"2025-03-14","current":-0.470191,"twenty":-9.227225,"median":-5.670316,"eighty":-0.675243,"marketCap":22443611},{"date":"2025-03-21","current":-0.53152,"twenty":-9.18875,"median":-5.509385,"eighty":-0.665195,"marketCap":25371039},{"date":"2025-03-28","current":-0.482968,"twenty":-9.161872,"median":-5.425609,"eighty":-0.655147,"marketCap":23053492},{"date":"2025-04-04","current":-0.408861,"twenty":-9.091808,"median":-5.407973,"eighty":-0.643893,"marketCap":19516184},{"date":"2025-04-11","current":-0.429305,"twenty":-9.050837,"median":-5.380674,"eighty":-0.631433,"marketCap":20491993},{"date":"2025-04-17","current":-0.472746,"twenty":-9.045443,"median":-5.362133,"eighty":-0.622992,"marketCap":22565587},{"date":"2025-04-25","current":-0.472746,"twenty":-9.037388,"median":-5.336421,"eighty":-0.57878,"marketCap":22565587},{"date":"2025-05-02","current":-0.39864,"twenty":-8.919003,"median":-5.165991,"eighty":-0.546852,"marketCap":19028279},{"date":"2025-05-09","current":-0.314156,"twenty":-8.857697,"median":-5.050076,"eighty":-0.534567,"marketCap":18784327},{"date":"2025-05-16","current":-0.354955,"twenty":-8.778159,"median":-5.035734,"eighty":-0.528965,"marketCap":21223850},{"date":"2025-05-23","current":-0.336596,"twenty":-8.694918,"median":-4.992187,"eighty":-0.51491,"marketCap":20126064},{"date":"2025-05-30","current":-0.385555,"twenty":-8.584144,"median":-4.945951,"eighty":-0.506094,"marketCap":23053492},{"date":"2025-06-06","current":-0.375355,"twenty":-8.389867,"median":-4.923647,"eighty":-0.48773,"marketCap":22443611},{"date":"2025-06-13","current":-0.346796,"twenty":-8.305941,"median":-4.87898,"eighty":-0.485012,"marketCap":20735945},{"date":"2025-06-20","current":-0.325376,"twenty":-8.294103,"median":-4.767993,"eighty":-0.472746,"marketCap":19455195},{"date":"2025-06-27","current":-0.316196,"twenty":-8.276767,"median":-4.744886,"eighty":-0.463426,"marketCap":18906303},{"date":"2025-07-03","current":-0.293756,"twenty":-8.257318,"median":-4.726928,"eighty":-0.447751,"marketCap":17564565},{"date":"2025-07-11","current":-0.677271,"twenty":-8.238715,"median":-4.597074,"eighty":-0.434085,"marketCap":40496081},{"date":"2025-07-18","current":-0.473274,"twenty":-8.204468,"median":-4.511228,"eighty":-0.43275,"marketCap":28298466},{"date":"2025-07-25","current":-0.471234,"twenty":-8.162188,"median":-4.172821,"eighty":-0.434085,"marketCap":28176490},{"date":"2025-08-01","current":-0.452874,"twenty":-8.09158,"median":-3.876104,"eighty":-0.433118,"marketCap":27078705},{"date":"2025-08-08","current":-0.417439,"twenty":-7.990847,"median":-0.854102,"eighty":-0.431093,"marketCap":21833730},{"date":"2025-08-15","current":-0.438428,"twenty":-7.911731,"median":-0.739552,"eighty":-0.423091,"marketCap":22931516},{"date":"2025-08-22","current":-0.437262,"twenty":-7.782512,"median":-0.719455,"eighty":-0.423091,"marketCap":22870528},{"date":"2025-08-29","current":-0.412775,"twenty":-7.72332,"median":-0.705388,"eighty":-0.422172,"marketCap":21589778},{"date":"2025-09-05","current":-0.387122,"twenty":-7.662014,"median":-0.692325,"eighty":-0.419594,"marketCap":20248040},{"date":"2025-09-12","current":-0.438428,"twenty":-7.579145,"median":-0.689311,"eighty":-0.417439,"marketCap":22931516},{"date":"2025-09-19","current":-0.405779,"twenty":-7.530963,"median":-0.677262,"eighty":-0.417439,"marketCap":21223850},{"date":"2025-09-26","current":-0.438428,"twenty":-7.458231,"median":-0.675243,"eighty":-0.417439,"marketCap":22931516},{"date":"2025-10-03","current":-0.482737,"twenty":-7.286722,"median":-0.66821,"eighty":-0.417768,"marketCap":25249063},{"date":"2025-10-10","current":-0.755588,"twenty":-7.269646,"median":-0.665195,"eighty":-0.419083,"marketCap":39520272},{"date":"2025-10-17","current":-0.839542,"twenty":-7.219361,"median":-0.673234,"eighty":-0.419594,"marketCap":43911414},{"date":"2025-10-24","current":-0.652977,"twenty":-7.152225,"median":-0.675243,"eighty":-0.421731,"marketCap":34153322},{"date":"2025-10-31","current":-0.643649,"twenty":-7.071889,"median":-0.671224,"eighty":-0.422103,"marketCap":33665417},{"date":"2025-11-07","current":-0.541038,"twenty":-6.870028,"median":-0.665195,"eighty":-0.422103,"marketCap":28298466},{"date":"2025-11-14","current":-0.515386,"twenty":-6.825412,"median":-0.656232,"eighty":-0.422103,"marketCap":26956729},{"date":"2025-11-21","current":-0.564098,"twenty":-6.824371,"median":-0.655309,"eighty":-0.422137,"marketCap":23747399},{"date":"2025-11-28","current":-0.640091,"twenty":-6.820206,"median":-0.655147,"eighty":-0.422275,"marketCap":26946530},{"date":"2025-12-05","current":-1.058049,"twenty":-6.768144,"median":-0.655228,"eighty":-0.424315,"marketCap":44541754},{"date":"2025-12-12","current":-0.929447,"twenty":-6.739119,"median":-0.659166,"eighty":-0.424435,"marketCap":39127839},{"date":"2025-12-19","current":-0.885605,"twenty":-6.703603,"median":-0.665195,"eighty":-0.429305,"marketCap":37282186},{"date":"2025-12-26","current":-0.935292,"twenty":-6.685845,"median":-0.66881,"eighty":-0.430327,"marketCap":39373926},{"date":"2026-01-02","current":-0.970366,"twenty":-6.655355,"median":-0.673234,"eighty":-0.431091,"marketCap":40850448},{"date":"2026-01-09","current":-1.046358,"twenty":-6.628277,"median":-0.677253,"eighty":-0.431431,"marketCap":44049580},{"date":"2026-01-16","current":-1.052204,"twenty":-6.612282,"median":-0.686296,"eighty":-0.431688,"marketCap":44295667},{"date":"2026-01-23","current":-1.198343,"twenty":-6.573971,"median":-0.69132,"eighty":-0.432106,"marketCap":50447843},{"date":"2026-01-30","current":-1.174961,"twenty":-6.526024,"median":-0.692622,"eighty":-0.433118,"marketCap":49463495},{"date":"2026-02-06","current":-1.131119,"twenty":-6.49406,"median":-0.700332,"eighty":-0.434085,"marketCap":47617842},{"date":"2026-02-13","current":-1.119428,"twenty":-6.432796,"median":-0.709407,"eighty":-0.434889,"marketCap":47125668},{"date":"2026-02-20","current":-1.417082,"twenty":-6.392718,"median":-0.721465,"eighty":-0.436096,"marketCap":59656302},{"date":"2026-02-27","current":-1.579698,"twenty":-6.311552,"median":-0.741418,"eighty":-0.436271,"marketCap":66502107},{"date":"2026-03-06","current":-1.506686,"twenty":-6.300499,"median":-0.776576,"eighty":-0.437029,"marketCap":63428480},{"date":"2026-03-13","current":3.453654,"twenty":-6.263811,"median":-0.766082,"eighty":-0.436096,"marketCap":102991419},{"date":"2026-03-20","current":3.272141,"twenty":-6.239871,"median":-0.739264,"eighty":-0.431983,"marketCap":97578518},{"date":"2026-03-27","current":3.502712,"twenty":-6.207714,"median":-0.72046,"eighty":-0.42956,"marketCap":104454365},{"date":"2026-04-02","current":2.997419,"twenty":-6.159768,"median":-0.708402,"eighty":-0.422275,"marketCap":89386018},{"date":"2026-04-10","current":2.413633,"twenty":-6.082077,"median":-0.697286,"eighty":-0.422103,"marketCap":71976957},{"date":"2026-04-17","current":2.806094,"twenty":-6.035463,"median":-0.692622,"eighty":-0.417439,"marketCap":83680528},{"date":"2026-04-24","current":3.178932,"twenty":-6.022144,"median":-0.69132,"eighty":-0.415107,"marketCap":94798920},{"date":"2026-05-01","current":2.747225,"twenty":-5.948893,"median":-0.680276,"eighty":-0.408861,"marketCap":81924992},{"date":"2026-05-08","current":2.774807,"twenty":-5.902278,"median":-0.675243,"eighty":-0.405779,"marketCap":92242897},{"date":"2026-05-15","current":3.187967,"twenty":-5.89118,"median":-0.671224,"eighty":-0.398783,"marketCap":105977593},{"date":"2026-05-22","current":2.805411,"twenty":-5.871202,"median":-0.665195,"eighty":-0.397362,"marketCap":93260282},{"date":"2026-05-29","current":5.258871,"twenty":-5.851102,"median":-0.663512,"eighty":-0.39318,"marketCap":174820638},{"date":"2026-06-05","current":7.141047,"twenty":-5.842359,"median":-0.656232,"eighty":-0.389082,"marketCap":237389810},{"date":"2026-06-12","current":6.477949,"twenty":-5.835059,"median":-0.655147,"eighty":-0.382672,"marketCap":215346470},{"date":"2026-06-18","current":6.585065,"twenty":-5.776198,"median":-0.652977,"eighty":-0.374539,"marketCap":218907317},{"date":"2026-06-26","current":6.095393,"twenty":-5.727363,"median":-0.648113,"eighty":-0.366749,"marketCap":202629159},{"date":"2026-07-02","current":6.426942,"twenty":-5.704278,"median":-0.643369,"eighty":-0.354955,"marketCap":213650829},{"date":"2026-07-10","current":6.421841,"twenty":-5.672314,"median":-0.640091,"eighty":-0.346796,"marketCap":213481264},{"date":"2026-07-17","current":7.758237,"twenty":-5.615045,"median":-0.634045,"eighty":-0.341492,"marketCap":257907072},{"date":"2026-07-24","current":7.84495,"twenty":-5.532027,"median":-0.629021,"eighty":-0.336596,"marketCap":260789662},{"date":"2026-07-31","current":13.931589,"twenty":-5.503974,"median":-0.624993,"eighty":-0.326396,"marketCap":463127824},{"date":"2026-08-07","current":14.271497,"twenty":-5.472684,"median":-0.618814,"eighty":-0.316196,"marketCap":482176783},{"date":"2026-08-14","current":13.54279,"twenty":-5.430703,"median":-0.608925,"eighty":-0.308852,"marketCap":457556692},{"date":"2026-08-21","current":13.974538,"twenty":-5.416038,"median":-0.598174,"eighty":-0.293756,"marketCap":472143730},{"date":"2026-08-28","current":14.230062,"twenty":-5.410968,"median":-0.593326,"eighty":1.875419,"marketCap":480776875},{"date":"2026-09-01","current":13.10223,"twenty":-5.409471,"median":-0.58768,"eighty":2.472502,"marketCap":442671959}],"updateTime":1788375290227},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QTTB\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2636027129","title":"Q32 Bio initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2636027129","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636027129?lang=en_us&edition=fundamental","pubTime":"2026-05-18 18:52","pubTimestamp":1779101552,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald initiated coverage of Q32 Bio (QTTB) with an Overweight rating. Published first on TheFly – the ultimate source for real-time, ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/q32-bio-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/q32-bio-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633139899","title":"Q32 Bio Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633139899","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633139899?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:34","pubTimestamp":1778074440,"startTime":"0","endTime":"0","summary":"Q32 Bio Inc reports results for the quarter ended March 31 - Earnings SummaryQ32 Bio Inc QTTB.OQ reported a quarterly adjusted loss of 54 cents per share for the quarter ended March 31, higher than th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL8N41J25B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633594242","title":"Q32 Bio Price Target Maintained With a $13.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2633594242","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633594242?lang=en_us&edition=fundamental","pubTime":"2026-05-06 00:23","pubTimestamp":1777998180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QTTB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2026 12:23 ET (16:23 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633578941","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Henry Schein (HSIC), Viridian Therapeutics (VRDN) and Q32 Bio (QTTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633578941","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633578941?lang=en_us&edition=fundamental","pubTime":"2026-05-05 22:50","pubTimestamp":1777992613,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Henry Schein (HSIC), Viridian Therapeutics (VRDN) and Q32 Bio (QT...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-henry-schein-hsic-viridian-therapeutics-vrdn-and-q32-bio-qttb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-henry-schein-hsic-viridian-therapeutics-vrdn-and-q32-bio-qttb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QTTB","XLV","LU0128526141.USD","HCSG","BK4588","LU0029874061.USD","BK4585","LABU","XBI","BK4175","HSIC","VRDN","BK4137","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633914726","title":"Q32 Bio Q1 EPS $(0.54) Beats $(0.68) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633914726","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633914726?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:09","pubTimestamp":1777979355,"startTime":"0","endTime":"0","summary":"Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.68) by 20.59 percent. This is a 40 percent increase over losses of $(0.90) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52276758/q32-bio-q1-eps-0-54-beats-0-68-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633914374","title":"Q32 Bio Q1 net loss narrows to $7.6 million; loss per share improves to $0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2633914374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633914374?lang=en_us&edition=fundamental","pubTime":"2026-05-05 18:59","pubTimestamp":1777978769,"startTime":"0","endTime":"0","summary":"Q32 Bio posted a net loss of USD 7.6 million, or USD 0.54 per share, for the quarter ended March 31, 2026, narrowing from a loss of USD 11 million, or USD 0.90 per share, a year earlier.Research and development expense fell to USD 3.2 million from USD 7.1 million, due to lower personnel-related costs, lower bempikibart clinical expense, and lower ADX-097 spend following the program sale in November 2025.General and administrative costs dipped to USD 4.5 million from USD 5.1 million on lower legal and consulting fees, while cash and cash equivalents rose to USD 50.8 million as of March 31, 2026.SIGNAL-AA Phase 2a Part B remained on track for a 36-week topline readout in mid-2026; first patient was dosed in the Part B open-label extension, with Part A OLE completed and findings expected alongside Part B results.Completed a USD 10.5 million registered direct offering; cash at quarter-end, combined with guaranteed near-term milestone payments from the ADX-097 asset sale and USD 14.2 millio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDLnq2Wr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633914524","title":"Press Release: Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633914524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633914524?lang=en_us&edition=fundamental","pubTime":"2026-05-05 18:59","pubTimestamp":1777978740,"startTime":"0","endTime":"0","summary":"-- Bempikibart 36-week topline data readout from Part B of SIGNAL-AA Phase 2a clinical trial on-track for mid-2026 --. -- First patient dosed in SIGNAL-AA Part B open-label extension  --. -- Completed $10.5 million registered direct offering  --. -- Cash and cash equivalents of $50.8 million as of March 31, 2026, combined with guaranteed near-term milestone payments from ADX-097 asset sale and proceeds from sales under at-the-market  program received after the end of the quarter, are expected to provide financial runway into 1H'2028 --. WALTHAM, Mass., May 5, 2026 /PRNewswire/ -- Q32 Bio Inc.  , a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata  and other autoimmune and inflammatory diseases, today reported financial results for the quarter ended March 31, 2026, and provided recent corporate updates.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LU2543165471.USD","AA","QTTB","BK4139","BK4153"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632395507","title":"Q32 Bio Inc  expected to post a loss of 68 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2632395507","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632395507?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:19","pubTimestamp":1777900744,"startTime":"0","endTime":"0","summary":"Q32 Bio Inc  expected to post a loss of68cents a share - Earnings Preview Q32 Bio Inc QTTB.OQ QTTB.O is expected to  show no change in quarterly revenue when it reports  results on May 6 (estimated) f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL8N41H1AE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631636805","title":"Q32 Bio announces annual shareholder meeting webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2631636805","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631636805?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:05","pubTimestamp":1777547102,"startTime":"0","endTime":"0","summary":"Q32 Bio set 2026 annual shareholder meeting for June 12, 2026, to be held online.Shareholders will vote on election of Class II directors Kathleen LaPorte, Jodie Morrison, Arthur Tzianabos.Meeting agenda includes ratification of Ernst & Young as independent registered public accounting firm for fiscal 2026.Advisory vote scheduled on compensation for named executive officers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q32 Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL4LVZHm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630822741","title":"Q32 Bio files prospectus for USD 75 million at-the-market stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2630822741","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630822741?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:11","pubTimestamp":1777061468,"startTime":"0","endTime":"0","summary":"Q32 Bio filed a new prospectus supplement to sell up to USD 75 million of common stock through its at-the-market program with Cantor Fitzgerald.Company completed its prior ATM tranche, selling USD 14.2 million of common stock under the earlier prospectus supplement.Additional shares will be issued off Q32 Bio’s effective Form S-3 shelf registration statement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q32 Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDLbfC4V0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625394873","title":"Q32 Bio to join Needham Virtual Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2625394873","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625394873?lang=en_us&edition=fundamental","pubTime":"2026-04-08 18:59","pubTimestamp":1775645959,"startTime":"0","endTime":"0","summary":"Q32 Bio management will join a fireside chat at Needham 25th Annual Virtual Healthcare Conference on April 15, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL9bVVVt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622803708","title":"Q32 Bio enters $14 million at-the-market equity distribution agreement; Cantor Fitzgerald commission set at 3.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622803708","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622803708?lang=en_us&edition=fundamental","pubTime":"2026-03-28 05:16","pubTimestamp":1774646191,"startTime":"0","endTime":"0","summary":"Q32 Bio entered a Controlled Equity OfferingSM sales agreement with Cantor Fitzgerald to sell common stock through an at-the-market program.The prospectus supplement covers up to USD 14.2 million of shares that may be offered and sold under the program.Cantor Fitzgerald will receive a 3% cash commission on gross proceeds from shares sold.Sales may be made on Nasdaq or other trading markets for the shares, subject to parameters set by Q32 Bio.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q32 Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsibl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDLc4g5lw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618941379","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Atricure (ATRC), Q32 Bio (QTTB) and Shoulder Innovations, Inc. (SI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618941379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618941379?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:20","pubTimestamp":1773228006,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Atricure (ATRC – Research Report), Q32 Bio (QTTB –...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-atricure-atrc-q32-bio-qttb-and-shoulder-innovations-inc-si-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-atricure-atrc-q32-bio-qttb-and-shoulder-innovations-inc-si-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QTTB","BK4082","BK4139","BK4588","SI","XBI","XLV","BK4137","LABU","LU0128526141.USD","ATRC","BK4211","LU0029874061.USD","BK4585","BK4581","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618291380","title":"Q32 Bio Faces Governance Backlash and Rising Costs After 2025 Stock Option Repricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2618291380","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618291380?lang=en_us&edition=fundamental","pubTime":"2026-03-11 14:01","pubTimestamp":1773208881,"startTime":"0","endTime":"0","summary":"Q32 Bio Inc (QTTB) has disclosed a new risk, in the Share Price & Shareholder Rights category. Q32 Bio Inc. faces governance and reputational risk ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/q32-bio-faces-governance-backlash-and-rising-costs-after-2025-stock-option-repricing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/q32-bio-faces-governance-backlash-and-rising-costs-after-2025-stock-option-repricing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618958993","title":"Q32 Bio Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2618958993","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618958993?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:39","pubTimestamp":1773146352,"startTime":"0","endTime":"0","summary":"Q32 Bio Inc reports results for the quarter ended December 31 - Earnings SummaryQ32 Bio Inc QTTB.OQ reported quarterly adjusted earnings of $5.52 per share for the quarter ended December 31, higher th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nL8N3ZY18W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618934946","title":"Q32 Bio Q4 net income hits USD 57.73 million as R&D expenses fall 69% to USD 3.32 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618934946","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618934946?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:00","pubTimestamp":1773140442,"startTime":"0","endTime":"0","summary":"Q32 Bio reported Q4 net income of USD 57.73 million, compared with a net loss a year earlier. Research and development expense fell 69% to USD 3.32 million, primarily due to lower bempikibart development and manufacturing costs, reduced ADX-097 spend after discontinuing its Phase 2 renal basket trial, and lower personnel-related costs. Cash and cash equivalents were USD 48.3 million at Dec. 31, and the company said this, plus gross proceeds from a USD 10.5 million registered direct offering and guaranteed near-term milestone payments from the ADX-097 sale, is expected to fund operations into Q4 2027. Q32 Bio said it completed enrollment in Part B of its SIGNAL-AA Phase 2a trial of bempikibart in alopecia areata and increased the trial size to 33 patients, with 36-week topline data expected in mid-2026. CEO Jodie Morrison said the company is encouraged by pharmacokinetic data and emerging signs of clinical activity in Part B.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDL8VjNnR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618345499","title":"Press Release: Q32 Bio Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2618345499","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618345499?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:59","pubTimestamp":1773140340,"startTime":"0","endTime":"0","summary":"-- Completed enrollment in Part B of SIGNAL-AA Phase 2a clinical trial and increased trial size to 33 patients based on patient demand; 36-week topline data readout expected in mid-2026 --. -- Completed asset sale of Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics to further enable Company's strategic focus on advancing bempikibart for alopecia areata  --. WALTHAM, Mass., March 10, 2026 /PRNewswire/ -- Q32 Bio Inc.  , a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata  and other autoimmune and inflammatory diseases, today reported financial results for the quarter ended December 31, 2025, and provided recent corporate updates.-- Completed enrollment in Part B of the SIGNAL-AA Phase 2a clinical trial. the SIGNAL-AA Phase 2a clinical trial is an open-label clinical trial","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4153","AA","BK4588","LU2543165471.USD","QTTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617638588","title":"Q32 Bio Inc  expected to post a loss of 86 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2617638588","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617638588?lang=en_us&edition=fundamental","pubTime":"2026-03-06 21:16","pubTimestamp":1772802967,"startTime":"0","endTime":"0","summary":"Q32 Bio Inc  expected to post a loss of86cents a share - Earnings Preview Q32 Bio Inc QTTB.OQ QTTB.O is expected to  show no change in quarterly revenue when it reports  results on March 9 (estimated)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nL8N3ZU1CF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":78,"code":"91000000","status":"200"}]}}